Hematological Toxicity in Mice after High Activity Injections of <sup>177</sup>Lu-PSMA-617

Prostate cancer (PC) is one of the most common malignancies affecting men, with poor prognosis after progression to metastatic castration-resistant prostate cancer (mCRPC). Radioligand therapy (RLT) targeting the overexpressed PSMA on PC cells, with, e.g., <sup>177</sup>Lu-PSMA-617, has...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Amanda Kristiansson, Oskar Vilhelmsson Timmermand, Mohamed Altai, Joanna Strand, Sven-Erik Strand, Bo Åkerström, Anders Örbom
格式: Artigo
語言:Inglês
出版: MDPI AG 2022-03-01
叢編:Pharmaceutics
主題:
radioligand therapy
<sup>177</sup>Lu-PSMA-617
prostate cancer
mouse model
hematotoxicity
在線閱讀:https://www.mdpi.com/1999-4923/14/4/731
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍